Stock data

美吾華 (1731)

美吾華 is a TWSE-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$142.28M, up 9.7% from a year earlier. EPS over the last four quarters totals NT$1.52.

Charts, drawing tools, and the P/E calculator are in the app, free to use.

Open 美吾華 in Insightr